[Prenatal studies of trisomy 21: triple test more efficient than age criterion].
?
['Cost-Benefit Analysis', 'Down Syndrome/*diagnosis', 'Humans', 'Infant, Newborn', 'Maternal Age', 'Pregnancy, High-Risk', '*Prenatal Diagnosis/economics', 'alpha-Fetoproteins/*analysis']